OA13.02 Phase II Trial of Pembrolizumab in Patients with Malignant Mesothelioma (MM): Interim Analysis

Hedy Kindler; Theodore Karrison; Yi-Hung Carol Tan; Buerkley Rose; Mehwish Ahmad; Christopher Straus; Robert Sargis; Tanguy Seiwert

首页> 外文期刊>Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer >OA13.02 Phase II Trial of Pembrolizumab in Patients with Malignant Mesothelioma (MM): Interim Analysis

【24h】

OA13.02 Phase II Trial of Pembrolizumab in Patients with Malignant Mesothelioma (MM): Interim Analysis

机译：恶性间皮瘤患者的彭布罗鲁替妥昔单抗的oA13.02期二期试验（mm）：临时分析

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 |2017年第1期|共2页
作者
Hedy Kindler; Theodore Karrison; Yi-Hung Carol Tan; Buerkley Rose; Mehwish Ahmad; Christopher Straus; Robert Sargis; Tanguy Seiwert;
展开▼
作者单位

Section of Hematology/Oncology University of Chicago;

Department of Public Health Sciences University of Chicago;

Section of Hematology/Oncology University of Chicago;

Section of Hematology/Oncology University of Chicago;

Section of Hematology/Oncology University of Chicago;

Department of Radiology University of Chicago;

Department of Medicine University of Chicago;

Section of Hematology/Oncology University of Chicago;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. OA13.02 Phase II Trial of Pembrolizumab in Patients with Malignant Mesothelioma (MM): Interim Analysis [J] . Hedy Kindler, Theodore Karrison, Yi-Hung Carol Tan, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2017,第1期

机译：恶性间皮瘤患者的彭布罗鲁替妥昔单抗的oA13.02期二期试验（mm）：临时分析
2. OA13.02 Phase II Trial of Pembrolizumab in Patients with Malignant Mesothelioma (MM): Interim Analysis [J] . Hedy Kindler, Theodore Karrison, Yi-Hung Carol Tan, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2017,第1期

机译：恶性间皮瘤患者的彭布罗鲁替妥昔单抗的oA13.02期二期试验（mm）：临时分析
3. OA08.03 Phase II Trial of Pembrolizumab (NCT02399371) In Previously-Treated Malignant Mesothelioma (MM): Final Analysis [J] . A. Desai, T. Karrison, B. Rose, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2018,第10期

机译：综合治疗恶性间皮瘤（MM）中PEMBROLIZUMAB（NCT02399371）的oA08.03期II期试验：最终分析
4. RISK-ADAPTED INTRAVENOUS MELPHALAN WITH ADJUVANT THALIDOMIDE AND DEXAMETHASONE FOR NEWLY DIAGNOSED UNTREATED PATIENTS WITH SYSTEMIC AL AMYLOIDOSIS: INTERIM REPORT OF A PHASE II TRIAL [C] . RL Comenzo, P Zhou, L Reich, International Symposium on Amyloidosis . 2005

机译：风险适应的静脉内莫尔甘蔗用佐剂沙利度胺和地塞米松，用于新诊断的未经治疗的全身淀粉样蛋白症患者：II期试验的中期报告
5. A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial of Fish Oil (Eicosapentaenoic Acid and Docosahexaenoic Acid) on Lung and Systemic Inflammation in Patients with Acute Lung Injury. [D] . Stapleton, Renee Doney. 2010

机译：鱼油（二十碳五烯酸和二十二碳六烯酸）对急性肺损伤患者的肺和全身炎症的II期，随机，双盲，安慰剂对照试验。
6. A single centre phase II trial to assess the immunological activity of TroVax® plus pemetrexed/cisplatin in patients with malignant pleural mesothelioma – the SKOPOS trial [O] . Jason F Lester, Angela C Casbard, Saly Al-Taei, 2018

机译：一项单一的中心II期临床试验评估TroVax®加培美曲塞/顺铂对恶性胸膜间皮瘤患者的免疫活性– SKOPOS试验
7. A multicentre randomized phase III trial comparing pembrolizumab (P) vs single agent chemotherapy (CT) for advanced pre-treated malignant pleural mesothelioma (MPM): Results from the European Thoracic Oncology Platform (ETOP 9-15) PROMISE-meso trial [O] . S. Popat, A. Curioni-Fontecedro, V. Polydoropoulou, 2019

机译：用于先进预处理的恶性胸膜间皮瘤（MPM）的Pembrolizumab（P）与单一药物化疗（CT）的多期式随机阶段III试验（CT）：欧洲胸肿瘤学平台（ETOP 9-15）承诺 - 中文试验结果

OA13.02 Phase II Trial of Pembrolizumab in Patients with Malignant Mesothelioma (MM): Interim Analysis

著录项

相似文献

相关主题

期刊订阅